Atlantic Union Bankshares 주식 (NYSE: AUB)

Atlantic Union Bankshares (NYSE:AUB) 주식

ATLANTIC UNION BANKSHARES CO

Atlantic Union Bankshares

Atlantic Union Bankshares Corp is a financial holding company and a bank holding company. Through its community bank subsidiary, the company provides financial services, including banking, trust, and wealth management. The bank is a full-service community bank offering consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from Wholesale Banking.

Atlantic Union Bankshares Corporation Common Stock

Atlantic Union Bankshares Corp

AUB Group Ltd

ASIA UTD BK CORP by ASIA UTD BK CORP.

Auburn National Bancorporation, Inc. - Common Stock

Auburn National Bancorp Inc

Atlantic Union Bankshares Corporation Depositary Shares each representing a 1/400th ownership interest in a share of 6.875% Perpetual Non-Cumulative Preferred Stock, Series A

Cantor Fitzgerald analyst Matthew Vanvliet reiterates Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a Overweight and maintains $325 price target.

News

Price Target

Reiteration

Analyst Ratings

Cantor Fitzgerald Reiterates Overweight on Salesforce, Maintains $325 Price Target

&#8220;It&#8217;s not that I&#8217;m lazy, it&#8217;s that I just don&#8217;t care.&#8221; That line from the 1999 cult classic &#8220;Office Space&#8221; movie might&#8217;ve gotten a laugh 26 years ago, but for a lot of working millennials today, it&#8217;s hitting uncomfortably close to home.
As one millennial recently put it in the r/Millennials <a href="https://www.reddit.com/r/Millennials/comments/1lahcem/the_older_i_get_and_the_farther_in_my_career_i_go/">subreddit</a>: &#8220;The older I get and the farther in my career I go, the more I realize how deadly accurate &#8216;Office Space&#8217; was.&#8221; That simple statement launched a tidal wave of agreement from thousands of people, most of them somewhere between their 30s and 40s, grinding through careers that feel increasingly pointless.
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">invest with $1,000 at just $0.30/share.</a></li>
</ul>
<h2 class="wp-block-heading">From Satire To Reality</h2>
When the movie first came out, many viewers saw it as an absurdist comedy. Now, it feels like a documentary. &#8220;It came out when I was in high school and I thought the exact same,&#8221; one person wrote. &#8220;I remember a couple years later in my first office job, like a week in I realized &#8216;it wasn&#8217;t satire, it was a f&#x2A;&#x2A;&#x2A;ing documentary.'&#8221;
Another echoed the sentiment: &#8220;Watched it again recently and was like &#8216;oh sh&#x2A;t.'&#8221;
A number of commenters shared that their daily work lives are basically spreadsheets, emails and meetings with no clear purpose. &#8220;People ask me what I do at my job, and I can't even explain it. I send emails and make spreadsheets, homie,&#8221; one person said. &#8220;My decks are basically full reports with a lot of data and they get referred to for years afterwards. I don&#8217;t even get to present them.&#8221;
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.
<h2 class="wp-block-heading">Promotions And Raises? Don&#8217;t Count On It</h2>
Many talked about doing great work, only to <a href="https://www.benzinga.com/personal-finance/management/25/06/45726529/four-and-a-half-years-in-a-worker-sees-a-new-hire-earn-20-more-now-theyre-asking-if-loyalty-is-the-most-expensive-career-mistake">get tiny raises</a> or none at all. &#8220;I crunched for three months at the beginning of 2025, usually 10-hour days with a couple of 12-hour days&#8230; Hit the target on both [projects], got a 0.5% raise shortly after. Lowest I&#8217;ve ever gotten, in a year where I easily did my best work,&#8221; someone wrote.&nbsp;
Another added, &#8220;Got a huge promotion/raise I&#8217;d been trying and failing to get for 5 years&#8221;—but only after they stopped putting in effort entirely after their dad passed away.
Several said it outright: if you care too much, you&#8217;re either ignored or punished. &#8220;The squeaky wheel gets more work assigned to them for no additional pay or prospects for promotion.&#8221;
<h2 class="wp-block-heading">Office Culture Is Dead</h2>
The idea of the workplace as a &#8220;family&#8221; was torn apart by users. One wrote, &#8220;I naively approached this job with &#8216;we&#8217;re a family&#8217; energy.&#8221; A year later? They keep to themselves now. &#8220;People are petty, insecure, control-hungry, arrogant, defensive. Humorless.&#8221;
Others pointed to open office layouts and <a href="https://www.benzinga.com/25/05/45556921/mark-zuckerberg-slams-endless-one-on-one-meetings-says-i-just-like-explode-without-open-blocks-of-time-in-the-calendar">endless meetings as morale-killers</a>. &#8220;I'm still wrapping my head around 30-minute daily standup meetings and then filling out a &#8216;What I Did Today&#8217; in Slack.&#8221;
See Also: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
<h2 class="wp-block-heading">Realizations Stack Up With Age</h2>
Many millennials admitted that the further they move up the corporate ladder, the more hollow it feels. One said their goal is now simply to &#8220;do half the work for twice the pay&#8221; as a program manager.
Others are focused on survival, not ambition. &#8220;You only have to work hard enough to be cheaper to keep than replace,&#8221; one comment read. And if there&#8217;s one consistent theme, it&#8217;s this: working hard doesn't guarantee anything.
One person summed up the entire vibe: &#8220;Watching that movie growing up it's like okay, that's kinda funny but he's not being serious. Now&#8230; now it's gospel.&#8221;
After thousands of comments, one thing is obvious: &#8220;Office Space&#8221; isn&#8217;t funny because it&#8217;s exaggerated—it's funny because it's true. And for a generation that grew up being told to find purpose in their work, discovering that the working world often rewards apathy instead of passion feels like a bait-and-switch.
Read Next: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Image: Shutterstock

A Millennial Says, The Older I Get And The Further In My Career I Go, The More I Realize How Deadly Accurate 'Office Space' Was

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081600/Taobao-0618-1.png" alt="" class="wp-image-14612" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081600/Taobao-0618-1.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081600/Taobao-0618-1-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081600/Taobao-0618-1-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
Embedded links in recommendation notes on the popular lifestyle platform will take buyers directly to items for sale in Alibaba's Tmall and Taobao marketplaces
Taobao and Tmall, two core marketplaces operated by&nbsp;Alibaba Group Holding Ltd.&nbsp;(BABA.US; 9988.HK), recently entered a landmark partnership with lifestyle social media sensation&nbsp;RedNote, in the former's latest step to bring its core e-commerce services closer to consumers in their everyday lives. The tie-up is just the latest by two of China's largest e-commerce marketplaces, as they look for new and innovative ways to engage consumers through steps like integrating links to products in online conversations and videos.
At the same time, Taobao and Tmall are giving their thousands of online merchants better tools to make their marketing and back-office functions more efficient, often using the power of AI. A company spokesperson discussed those developments and more in a recent interview with Bamboo Works.
Q:&nbsp;Taobao and Tmall have recently announced a partnership with RedNote. Could you tell us more about the collaboration?
A: Taobao and Tmall's strategic partnership with RedNote represents a significant step in bridging content and commerce, offering consumers a seamless path from product discovery to purchase. The partnership enables merchants to embed product links from their Taobao and Tmall stores directly into recommendation posts on RedNote. Users can tap on these links and be redirected to the Taobao app to complete their purchases.
The partnership also includes the launch of joint merchant accounts and performance dashboards, allowing merchants to track the full journey from content exposure on RedNote to completed orders on the Taobao app in real-time. To further support merchant success, Taobao and Tmall will invest in amplifying hero products featured in RedNote posts, providing marketing resources and performance advertising tools to boost product visibility and engagement.
Q: Is this the first time Taobao and Tmall have struck such a major partnership with an outside company and what's the strategic importance?
A: We have a strong track record of successful partnerships with other platforms as part of our "user-first" strategy and merchant-friendly initiatives. Currently, Taobao and Tmall work with over 200 internet platforms, ranging from social media to mobile payments, supporting brand growth through expanded traffic channels, diversified content formats, and omni-channel operations.
Last September, Taobao and Tmall partnered with WeChat Pay, which expanded payment options for consumers. Additionally, last October, JD Logistics fully integrated with Taobao and Tmall, providing comprehensive services to Taobao and Tmall merchants that encompass the entire supply chain process, including warehousing, express delivery, and freight.
These developments represent significant milestones for China's cross-platform interconnectivity and enhancing Taobao and Tmall's competitiveness. All these partnerships create a more seamless and convenient experience for consumers while opening up new business opportunities for merchants, benefitting both.
Q: Do you see content-driven e-commerce as key to driving further user and business growth, and can you elaborate on how?
A: The partnership between Taobao and Tmall and RedNote bridges content with commerce, reflecting our commitment to supporting brands. At its TopTalk annual merchant conference in March, Tmall announced a series of new initiatives to support brands in 2025, including measures to attract users across channels and the extension of its commission rebate scheme to cover all categories.
Tmall President Liu Bo said the RedNote collaboration marks a new chapter in the marketplace's support for brand growth in 2025. He added that combining Taobao and Tmall's commerce expertise with RedNote's strength in lifestyle content, will help brands reach consumers more effectively and drive incremental growth.
Q: What other initiatives are Taobao and Tmall taking to enhance overall user experience and overall stickiness?
A: With 1 billion annual active consumers, Taobao and Tmall are continuously introducing new initiatives to enhance user experience. To convert more new users into loyal consumers and ultimately VIP members, Taobao and Tmall will increase investment in initiatives such as exclusive 88VIP benefits this year, aiming to cultivate repurchasing habits and deepen long-term engagement.
To boost repeat purchases, Tmall is increasing investment in not only platform-wide loyalty programs like 88VIP but also in brand-specific ones. Brands will be able to increase member engagement through more membership access points across Taobao search results, personalized recommendations, and shopping carts.
Q: I understand Alibaba has leveraged AI-powered technology to support merchants on your e-commerce platforms. Can you tell us more about these tools?
A: Taobao and Tmall have been integrating advanced AI technologies into every stage of the e-commerce process, from product recommendations and bidding optimization to content creation and performance analytics. These AI tools are designed to transform the digital shopping experience while boosting operating efficiency for merchants.
At the 2025 TopTalk conference, we introduced major upgrades to the merchant AI toolkit, including new image-to-video generation capabilities within the AI-generated Content (AIGC) tool and an advanced marketing bidding model that has demonstrated an average 12% boost in campaign ROI through automated bidding strategies. Additionally, our AI customer service chatbots have continued to evolve, offering increasingly sophisticated support.
To date, Taobao and Tmall's AI-powered e-commerce toolkit, launched last year, has served 7 million merchants. This May alone, merchants reduced their marketing expenses by generating over 100 million marketing images, videos, and text and conducted over 1.8 million AI agent services for traffic analysis and more.
Our new "Image-to-Video" AIGC product has generated over 1.5 million videos since its beta launch in April. It enables merchants to generate up to 20-second videos from one or more product images, and provides additional features such as one-click editing, smart refinement, and script-based production
Q: Can you tell us about your Quanzhantui marketing solution?
A: Quanzhantui launched in April 2024 and is an important AI-powered marketing tool to help merchants market effectively and drive business growth. Over 1.4 million merchants have enhanced their marketing efficiency with the aid of Quanzhantui. As our CEO Eddie Wu explained in our earnings call last August, achieving strong sales performance requires more than just having a product in place, and Quanzhantui can help merchants to streamline operations and optimize marketing efficiency.
For the quarter through March this year, our customer management revenue grew 12% year-over-year to 71.1 billion yuan ($9.8 billion), primarily driven by the improvement of take rate, which benefited from the impact of software service fees and the increasing penetration of Quanzhantui.
Q: How are these new products and offerings driving user growth?
A: Taobao and Tmall are committed to enhancing support for product launches, providing brands with powerful tools and resources to capture market share and attract new consumers. Specifically, Taobao and Tmall have introduced new marketing tools that leverage AI and data analytics, along with more prominent ad placements and an extended new product incubation cycle from 30 days to 90 days, giving brands more time to build awareness and gain traction.
The "Tmall Super Launch" campaign has been particularly successful, enabling 34,000 new products to achieve sales exceeding 10 million yuan each. This feature alone generated a total of 100 billion yuan in sales in 2024.

Equities

Opinion

Trading Ideas

Interview

BABA

Alibaba Talks To Bamboo Works On RedNote Partnership

Cantor Fitzgerald analyst Eric Schmidt reiterates Prothena Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTA#NASDAQ">PRTA</a>) from Neutral to Neutral.

PRTA

Cantor Fitzgerald Reiterates Neutral on Prothena Corpto Neutral

Accenture Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) stock declined on Friday following the release of its <a href="https://www.benzinga.com/pressreleases/25/06/b46022011/accenture-reports-third-quarter-fiscal-2025-results">third-quarter 2025 results</a>.
The company reported quarterly earnings of $3.49 per share, topping the <a href="https://www.benzinga.com/earnings">analyst consensus estimate of $3.31</a>.
The company reported sales of $17.7 billion, slightly exceeding the analyst consensus estimate of $17.30 billion. Sales increased 8% in U.S. dollars and 7% in local currency.
Also Read: <a href="https://www.benzinga.com/news/large-cap/25/05/45538647/accenture-dell-nvidia-deliver-on-premise-ai-solution-for-regulated-industries" target="_blank" rel="noreferrer noopener">Accenture, Dell, NVIDIA Deliver On-Premise AI Solution For Regulated Industries</a>
Consulting revenues were $9.01 billion, an increase of 7% in U.S. dollars and 6% in local currency. Managed Services revenues reached $8.72 billion, an increase of 9% in U.S. dollars and local currency.
Products revenues reached $5.34 billion, up 7% both in U.S. dollars and local currency. Health &amp; Public Service revenues increased by 7% in U.S. dollars and local currency to $3.78 billion.
Financial Services revenue reached $3.28 billion, up 13% in U.S. dollars and local currency. Resources revenue was $2.41 billion, up 5% in U.S. dollars and 4% in local currency.
Communications, Media &amp; Technology revenue was $2.91 billion, up 5% both in U.S. dollars and in local currency.
New bookings for the quarter were $19.7 billion, a decrease of 6% in U.S. dollars and 7% in local currency. This total comprised $9.08 billion in Consulting new bookings and $10.62 billion in Managed Services new bookings.
Generative AI new bookings reached $1.5 billion in the quarter <a href="https://www.benzinga.com/25/03/44415440/accenture-q2-fy2025-earnings-almost-inline-with-expectations-new-bookings-fall-to-209-billion-tightens-annual-sal">versus $1.4 billion</a> in the second quarter.
Operating margin of 16.8%, an increase of 80 basis points, and a rise of 40 basis points compared to adjusted&nbsp;operating margin.
Accenture held $9.64 billion in cash and equivalents as of May 31. It generated $3.52 in free cash flow during the quarter.
Accenture has declared $1.48 per share dividend, payable on August 15, 2025. During the third quarter of fiscal 2025, Accenture repurchased or redeemed 6 million shares for a total of $1.8 billion, including 5.7 million shares acquired through open market transactions. As of May 31, 2025, Accenture had approximately $3.3 billion remaining in its share repurchase authority and about 623 million total shares outstanding.
Accenture announced a <a href="https://www.benzinga.com/pressreleases/25/06/b46022235/accenture-changes-growth-model-to-reinvent-itself-for-the-age-of-ai">strategic overhaul of its growth model</a>, effective September 1, 2025, with a sharpened focus on AI. As part of this change, the company will launch a new Reinvention Services unit.
Leadership changes associated with this new structure include Manish Sharma, Accenture&#8217;s current CEO of the Americas, transitioning to Chief Services Officer. John Walsh, Accenture&#8217;s current global COO, will succeed Sharma as CEO of the Americas. Kate Hogan, currently COO of the Americas, will become the global COO, succeeding Walsh.
Guidance: Accenture narrowed its fiscal year 2025 revenue growth outlook to 6%-7% (prior 5%-7%) in local currency. The company forecasts 2025 diluted earnings of $12.77-$12.89 (prior $12.55-$12.79) per share compared <a href="https://www.benzinga.com/calendars/guidance">to the consensus of $12.75</a>.
Price Action: ACN stock was trading lower by 5.19% to $290.47 premarket at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46005368/meta-amazon-booking-best-positioned-for-agentic-ai-opportunity-says-analyst" target="_blank" rel="noreferrer noopener">Meta, Amazon, Booking Best Positioned For Agentic AI Opportunity, Says Analyst</a></li>
</ul>
Photo via Shutterstock

Earnings

Guidance

Movers

Tech

Accenture New Bookings Fall In Q3, But It Raises Profit Outlook

WIIM

Kroger shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results.

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081847/Alphamab.png" alt="" class="wp-image-14615" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081847/Alphamab.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081847/Alphamab-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/19081847/Alphamab-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The founder of the cancer drug developer has cashed out part of his holdings after the stock hit a price peak, raising questions about the firm's earnings outlook
Key Takeaways:
<ul class="wp-block-list">
<li>The company finally posted an annual profit last year, but the achievement came on the back of upfront licensing payments for its experimental drugs</li>
<li>Rights to Alphamab's advanced drug candidates in mainland China have now been licensed out, capping the firm's growth potential from here</li>
</ul>
China's drug discovery sector has roared back to life this year after a three-year slump, leading a rally in the overall Hong Kong stock market.
One of the standout performers has been cancer therapy specialist&nbsp;Alphamab Oncology&nbsp;(9966.HK), which more than doubled in market value, outstripping a 65% overall jump in the Hang Seng Innovative Drug Index.
But the rebound has also tempted shareholders to cash out their winnings.
Last Friday, Alphamab&nbsp;<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0606/2025060601575.pdf">announced</a>&nbsp;that a family trust controlled by a key shareholder had sold a block of 14.6 million shares on June 5 for approximately HK$117 million. The divestment at HK$8.05 ($1.03) per share reduced the stake controlled by founder and chairman Xu Ting to 31% from 32.5%, although he retains a majority interest.
The sale took advantage of an elevated price after Alphamab stock hit its highest level since November 2023, riding on a wave of positive news for the industry.
The rally was fueled by a $6 billion landmark licensing deal between&nbsp;3SBio&nbsp;(1530.HK) and&nbsp;Pfizer&nbsp;(PFE.US), as well as a 25% surge by industry leader&nbsp;Hengrui Pharmaceuticals&nbsp;(600276.SH; 1276.HK) after its Hong Kong stock market debut. Alphamab's share price duly rose nearly 33% between May 19 and May 23. Just over a week later on June 2 the company began the share sale process, which was completed a few days afterwards.
Alphamab specializes in developing biopharmaceuticals for the targeted treatment of tumors. One of its key products is the immune checkpoint drug envafolimab, a PD-L1 oncology product approved in 2021. After being in business for nine years, the company finally achieved its first full-year profit in 2024. While on paper the company looks to be reaping the rewards of its research efforts, the quick cash-out rings an alarm bell for investors.
A closer look at Alphamab's earnings record sheds some light on the motivation behind the move.
The company's annual revenues leapt 192% to 640 million yuan ($8.9 million) last year, pushing its bottom line from a net loss of 211 million yuan in 2023 to a profit of 166 million yuan. But core revenue from the only Alphamab drug launched so far on the market, envafolimab, actually fell 18.46% to 159 million yuan from the prior year. The decisive factor for profits was actually proceeds from three licensing agreements, amounting to around 464 million yuan in one-off fees and 1.88 million yuan in staggered payments.
<h4 class="wp-block-heading">Deals momentum flagging</h4>
It was a big year for drug development deals. In January, Alphamab inked a $700 million agreement with Glenmark for envafolimab, a $616 million deal with ArriVent for joint work on antibody-drug conjugates, and a 3.08 billion yuan deal with&nbsp;CSPC Pharmaceutical Group&nbsp;(1093.HK) for the dual-target HER2 antibody-drug conjugate JSKN003.
Those headline amounts include upfront fees and milestone payments, but the deferred sums depend on hitting defined R&amp;D targets and may not ultimately materialize. The parties did not disclose specific figures for upfront payments in the first two collaborations, while the upfront payout for the deal with CSPC Pharmaceutical Group was a mere 400 million yuan.
The track record for previous Alphamab deals highlights the risks. Its U.S. partner&nbsp;Tracon Pharmaceuticals&nbsp;(TCON.US) pulled the plug on joint development of envafolimab after the drug delivered disappointing trial results when used in a combined therapy to treat sarcoma patients. A Phase Three trial for Alphamab's other core product, KN046 for pancreatic cancer, also failed to achieve the targeted survival endpoint. Previous trials of KN046 to treat a type of lung cancer also yielded unsatisfactory results.
Otherwise, rights within mainland China to Alphamab's two other advanced pipelines, KN026 and JSKN003, have also been licensed out to CSPC Pharmaceutical Group. Even if those drugs are successfully launched in China, Alphamab will only receive a portion of the proceeds, limiting its earnings growth potential. Moreover, the firm's HER2 antibody-drug conjugate, JSKN003, faces fierce competition from Zymeworks, Chia Tai Tianqing, and XuanZhu Biopharm, which are working on similar products.
Licensing deals may bump up the bottom line in the short term but only sustained returns from commercially viable drugs can offer a stable income.
Currently, Alphamab trades at a price-to-earnings (P/E) ratio of 44 times, even higher than the 30 times for&nbsp;Henlius Biotech&nbsp;(2696.HK), which has achieved profitability through product sales. Alphamab's numerous collaborations demonstrate its R&amp;D expertise but leave investors at risk of a setback if profits prove to be fleeting.

Asia

Asset Sales

Alphamab Stake Sale Could Signal Harder Times Ahead

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">211.66</td>
<td align="right">1.23</td>
<td align="right">0.58</td>
<td>7.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">50.43</td>
<td align="right">0.21</td>
<td align="right">0.41</td>
<td>285.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">88.40</td>
<td align="right">0.32</td>
<td align="right">0.36</td>
<td>366.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">133.59</td>
<td align="right">0.35</td>
<td align="right">0.26</td>
<td>2.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">242.16</td>
<td align="right">0.55</td>
<td align="right">0.22</td>
<td>11.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">87.11</td>
<td align="right">0.10</td>
<td align="right">0.11</td>
<td>932</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">103.55</td>
<td align="right">0.08</td>
<td align="right">0.07</td>
<td>1.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">142.31</td>
<td align="right">0.10</td>
<td align="right">0.07</td>
<td>1.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">80.59</td>
<td align="right">0.03</td>
<td align="right">0.03</td>
<td>1.2K</td>
</tr>
</tbody>
</table>
No loser in today's Pre-market session. 
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> the above sector movers alert assists traders in understanding macro-level trends and market variations. Traders will look for sector movers providing information on sectors that are over- or under-performing, deriving these results into investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

ETFs

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For June 20, 2025

UBS maintains Lundin Mining (TSX:<a class="ticker" href="https://www.benzinga.com/stock/LUN#TSX">LUN</a>) with a Neutral and raises the price target from C$13 to C$14.

TSX:LUN

UBS Maintains Neutral on Lundin Mining, Raises Price Target to C$14

Cantor Fitzgerald analyst Li Watsek initiates coverage on Replimune Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REPL#NASDAQ">REPL</a>) with a Overweight rating.

Initiation

REPL

Cantor Fitzgerald Initiates Coverage On Replimune Group with Overweight Rating

<a href="https://about.fb.com/news/2025/06/introducing-oakley-meta-glasses-a-new-category-of-performance-ai-glasses/" title="https://about.fb.com/news/2025/06/introducing-oakley-meta-glasses-a-new-category-of-performance-ai-glasses/">https://about.fb.com/news/2025/06/introducing-oakley-meta-glasses-a-new-category-of-performance-ai-glasses/</a>

Meta Announces Oakley Meta Glasses, Releasing July 11 For $499; Rest Of Collection At $399 Later This Summer

BASE

Couchbase To Be Acquired By Haveli Investments For $24.50 Per Share In Cash

Offerings

LGCL

Lucas GC Limited Announces Pricing Of 32,150,000 Share Follow-On Offering At Public Offering Price Of $0.20/Share

CDZI

Cadiz Signs Signs MOU With MOU To Develop A Clean Energy Campus At Cadiz Ranch In The Mojave Desert

10 analysts have expressed a variety of opinions on Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $23.0, a high estimate of $32.00, and a low estimate of $17.00. A 20.69% drop is evident in the current average compared to the previous average price target of $29.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1750424465_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A clear picture of Helmerich &amp; Payne's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$17.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Sean Meakim</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$17.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$19.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Daniel Kutz</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$20.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$20.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$25.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Charles Minervino</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$28.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Neil Mehta</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$25.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$32.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Daniel Kutz</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Underweight</td>
<td>$27.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Helmerich &amp; Payne. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Helmerich &amp; Payne compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Helmerich &amp; Payne's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Helmerich &amp; Payne's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Helmerich &amp; Payne analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Delving into Helmerich &amp; Payne's Background</h2>
Helmerich &amp; Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.
<h3>Unraveling the Financial Story of Helmerich &amp; Payne</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Helmerich &amp; Payne's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 47.69%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Energy sector.
Net Margin: Helmerich &amp; Payne's net margin excels beyond industry benchmarks, reaching 0.12%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Helmerich &amp; Payne's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.04%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Helmerich &amp; Payne's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.02%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.76.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Helmerich & Payne's Future

Providing a diverse range of perspectives from bullish to bearish, 15 analysts have published ratings on Progressive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) in the last three months.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">9</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $306.47, a high estimate of $333.00, and a low estimate of $287.00. Surpassing the previous average price target of $302.80, the current average has increased by 1.21%.
<img src="https://www.benzinga.com/files/images/story/2025/1750424457_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Progressive. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$333.00</td>
<td>$328.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$291.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Bob Huang</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$330.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$328.00</td>
<td>$324.00</td>
</tr>
<tr>
<td>Bob Huang</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$320.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$324.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>Michael Zaremski</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$288.00</td>
<td>$282.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$288.00</td>
<td>$288.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$297.00</td>
<td>$289.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$297.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Yaron Kinar</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$319.00</td>
<td>$327.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$320.00</td>
<td>$317.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$288.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$287.00</td>
<td>$267.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$287.00</td>
<td>$300.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Progressive. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Progressive compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Progressive's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Progressive's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PGR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Progressive analyst ratings.</a>
<h2>About Progressive</h2>
Progressive underwrites private and commercial auto insurance and specialty lines; it has almost 24 million personal auto policies in force and is one of the largest auto insurers in the United States. Progressive markets its policies through independent insurance agencies in the US and Canada and directly via the internet and telephone. Its premiums are split roughly equally between the agent and the direct channel. The company also offers commercial auto policies and entered homeowners insurance through an acquisition in 2015.
<h3>Progressive: A Financial Overview</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Over the 3M period, Progressive showcased positive performance, achieving a revenue growth rate of 18.36% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: Progressive's net margin is impressive, surpassing industry averages. With a net margin of 12.58%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 9.41%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Progressive's ROA excels beyond industry benchmarks, reaching 2.36%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.24.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Progressive Through The Eyes Of 15 Analysts

7 analysts have shared their evaluations of Cactus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHD#NYSE">WHD</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $54.0, a high estimate of $61.00, and a low estimate of $50.00. Observing a downward trend, the current average is 3.07% lower than the prior average price target of $55.71. 
<img src="https://www.benzinga.com/files/images/story/2025/1750424445_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The perception of Cactus by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$53.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$54.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$52.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$51.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Stephen Gengaro</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$57.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Stephen Gengaro</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$61.00</td>
<td>$64.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cactus. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Cactus compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Cactus's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Cactus's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/WHD/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Cactus analyst ratings.</a>
<h2>Discovering Cactus: A Closer Look</h2>
Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.
<h3>Key Indicators: Cactus's Financial Health</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Cactus's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 2.26%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.
Net Margin: Cactus's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 15.78% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Cactus's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.06%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.52%, the company showcases effective utilization of assets.
Debt Management: Cactus's debt-to-equity ratio is below the industry average at 0.04, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

7 Analysts Have This To Say About Cactus

Throughout the last three months, 10 analysts have evaluated TPG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $56.4, a high estimate of $68.00, and a low estimate of $42.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 16.1%. 
<img src="https://www.benzinga.com/files/images/story/2025/1750424438_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive TPG. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steven Chubak</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$60.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$58.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$56.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Benjamin Rubin</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$62.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Michael Cyprys</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$47.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Bill Kirk</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$42.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$52.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Christopher Allen</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$56.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Craig Siegenthaler</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$68.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Alexander Blostein</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$63.00</td>
<td>$70.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to TPG. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of TPG compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of TPG's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into TPG's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TPG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on TPG analyst ratings.</a>
<h2>Unveiling the Story Behind TPG</h2>
TPG Inc is an alternative asset management firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company focuses on large-scale, control-oriented private equity investments.
<h3>TPG: Delving into Financials</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining TPG's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 17.1% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: TPG's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 1.37%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): TPG's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 1.22%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): TPG's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.09%, the company may face hurdles in achieving optimal financial performance.
Debt Management: TPG's debt-to-equity ratio is notably higher than the industry average. With a ratio of 2.55, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Basics of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 10 Analysts Discuss TPG Stock

Morningstar's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MORN#NYSE">MORN</a>) short percent of float has fallen 7.43% since its last report. The company recently reported that it has 510 thousand shares sold short, which is 1.87% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.84 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Morningstar Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750424428_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Morningstar has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Morningstar's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Morningstar's peer group average for short interest as a percentage of float is 5.89%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

MORN

How Is The Market Feeling About Morningstar?

Politics

General

iShares MSCI Israel Capped Investable Market Index Fund

Reuters Reports Israeli Media Says Initial Reports Indicate Missile Impacts In Tel Aviv, The Negev And Haifa

Press Releases

Atlantic Union Bankshares Reports Fourth Quarter and Full Year Financial Results

Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend

Atlantic Union Bankshares Corporation and Sandy Spring Bancorp, Inc. Announce Receipt of All Shareholder and Bank Regulatory Approvals to Complete Merger

Comments

Atlantic Union Bankshares

뉴스

파트너 / 기고자

벤징가 글로벌